Biochemical and pharmacological characterization of multiple β-endorphinergic antinociceptive systems in the rat periaqueductal gray

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 1, 1996, Pages 65-73

  Monroe, Philip J ^a   Hawranko, Alyssa A ^a   Smith, Deborah L ^a   Smith, David J ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLLYSYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; MORPHINE; NALTREXONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; MALE; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT;

AMINO ACID SEQUENCE; ANIMALS; BETA-ENDORPHIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; IODINE RADIOISOTOPES; MALE; MOLECULAR SEQUENCE DATA; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; NOCICEPTORS; OPIOID PEPTIDES; PEPTIDE FRAGMENTS; PERIAQUEDUCTAL GRAY; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; SOMATOSTATIN;

EID: 0029916069     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. AKIL, H., YOUNG, E., WATSON, S. J. AND COY, D. H.: Opiate binding properties of naturally occurring N- and C-terminus modified beta-endorphins. Peptides 2: 289-292, 1981.
2. BERGE, O. G., CABRERA, I. G. AND HOLE, K.: Response latencies in the tail-flick test depend on tail skin temperature. Neurosci Lett. 86: 284-288, 1988.
3. BERGE, O. G. AND TJOLSEN, A.: Tail-flicks, temperatures and latencies: Comments on Lichtman et al., Pain 55: 283-295, 1993. Pain 57: 256-257, 1994.
4. BERGE, O. G. AND TJOLSEN, A.: Tail-flicks, temperatures and latencies: Comments on Lichtman et al., Pain 55: 283-295, 1993. Pain 57: 256-257, 1994.
5. BLOOM, A. S. AND TSENG, L.-F.: Effects of β-endorphin on body temperature in mice at different ambient temperatures. Peptides 2: 293-297, 1981.
6. BRADBURY, A. F., SMYTH, D. G , SNELL, C R., BIRDSALL, N. J. M. AND HULME, E. C.. C fragment of lipotropin has a high affinity for brain opiate receptors. Nature (Lond.) 260: 793-795, 1976.
7. D'AMOUR, F. E. AND SMITH, D. L.: A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72: 74-79, 1941.
8. FEDYNYSHYN, J. P., KWIAT, G. AND LEE, N. M.: Characterization of high affinity opioid binding sites in rat periaqueductal gray P2 membrane. Eur. J. Pharmacol. 159: 83-88, 1989.
9. GOLDSTEIN, A. AND NAIDU, A : Multiple opioid receptors: Ligand selectivity profiles and binding site signatures. Mol. Pharmacol. 36: 265-272, 1989.
10. GOODMAN, R. R. AND PASTERNAK, G. W.: Multiple opiate receptors. In Analgesics: Neurochemical, Behavioral and Clinical Perspectives, ed. by M. Kuhar and G. Pasternak, pp. 69-96. Raven Press, New York, 1984.
11. HAWRANKO, A. A., MONROE, P. J. AND SMITH, D. J.. Pain facilitory and inhibitory systems are activated by β-endorphin: Stress enhances facilitation. Soc. Neurosci. Abstr., vol. 21, part 2, p. 1169, 1995.
12. HEINRICHER, M. M., MORGAN, M. M., TORTORICI, V. AND FIELDS, H. L.: Disinhibition of off-cells and antinociception produced by an opioid action within the rostral ventromedial medulla. Neuroscience 63: 279-288, 1994.
13. HONG, M., SUTAK, M. AND JHAMANDAS, K.: Inhibition of spinal opioid antinociception by intrathecal β-endorphin1-27 in the rat. Br. J. Pharmacol. 108: 1137-1142, 1993.
14. KAZMIERSKI, W., WIRE, W. S., LUI, G. K., KNAPP, R. J., SHOOK, J. E., BURKS, T. F., YAMAMURA, H. I. AND HRUBY, V. J.: Design and synthesis of somatostatin analogues with topographical properties that lead to highly potent and specific μ opioid receptor antagonists with greatly reduced binding at somatostatin receptors. J. Med. Chem. 31: 2170-2177, 1988.
15. LICHTMAN, A. H. AND MARTIN, B. R.: Changes in tail skin temperature are unlikely to be a confounding factor I the tail-flick test. Pain 57: 257-258, 1994.
16. LUND, A., TJOLSEN, A. AND HOLE, K.: The apparent antinociceptive effects of desipramine and zimelidine in the tail flick test in rats is mainly caused by changes in tail skin temperature. Pain 38: 65-69, 1989.
17. MAIER, S. F., WIERTLAK, E. P. AND WATKINS, L. R.: Endogenous pain facilitory systems. Am. Pain. Soc. J. 1: 191-198, 1992.
18. MELZIG, M. F. AND TERENIUS, L.: Non-opioid binding sites for beta-endorphin and in vitro effects in different cell lines. Regul. Peptides 50: Suppl. 1, 249-250, 1994.
19. MUNSON, P. J. AND RODBARD, D.: LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107: 220-239, 1980.
20. PARVINI, S., HAMANN, S. R. AND MARTIN, W. R.: Pharmacological characteristics of a medullary hyperalgesic center. J. Pharmacol. Exp. Ther. 265: 286-293, 1993.
21. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates, 2nd ed., Academic Press, New York, 1986.
22. ROTHMAN, R. B.: A review of the role of anti-opioid peptides in morphine tolerance and dependence. Synapse 12: 129-138, 1992.
23. 1-31 on murine splenocyte proliferation via a naloxone-resistant receptor. Biochem. Biophys. Res. Commun. 175: 936-942, 1991.
24. SHAHABI, N. A., PETERSON, P K. AND SHARP, B.: ß-Endorphin binding to naloxone-insensitive sites on a human mononuclear cell line (U937): Effects of cations and guanosine triphosphate. Endocrinology 126: 3006-3015, 1990.
25. SHOOK, J. E., KAZMIERSKI, W., WIRE, W. S., LEMCKE, P. K., HRUBY, V. J. AND BURKS, T. F.: Opioid receptor selectivity of ß-endorphin in vitro and in vivo: Mu, delta and epsilon receptors. J. Pharmacol. Exp. Ther. 246: 1018-1025, 1988.
26. SHOOK, J. E., PELTON, J. T., LEMCKE, P. K., PORRECA, F., HRUBY, V. J. AND BURKS, T F.: Mu opioid antagonist properties of a cyclic somatostatin analog in vivo: Identification of mu-related function. J. Pharmacol Exp. Ther. 242: 1-7, 1987.
27. SMITH, D. J., MONROE, P. J. AND HAWRANKO, A. A. (1994) Multiple opioid receptors mediate descending pain modulation from the periaqueductal grey (PAG). Regul. Peptides 50: Suppl. 1, 99-100, 1994.
28. SMITH, D. J., PERROTTI, J. M , CRISP, T., CABRAL, M E. Y., LONG, J. T. AND SCALZITTI, J. M.: The μ opiate receptor is responsible for descending pain inhibition originating in the periaqueductal gray region of the rat brain. Eur. J. Pharmacol. 156: 47-54, 1988.
29. SMITH, D J., ROBERTSON, B. AND MONROE, P. J.: Antinociception from the administration of ß-endorphin into the periaqueductal gray of rat is enhanced while that of morphine is inhibited by barbiturate anesthesia. Neurosci. Lett. 146: 143-146, 1992a.
30. SMITH, D. J., ROBERTSON, B., MONROE, P. J , TAYLOR, D. A., LEEDHAM, J. A. AND CABRAL, J. D. Y.: Opioid receptors mediating antinociception from ß-endorphin and morphine in the periaqueductal gray. Neuropharmacology 31: 1137-1150, 1992b.
31. SUH, H. H., FUJIMOTO, J. M. AND TSENG, L. F.: Differential mechanisms mediating β-endorphin- and morphine-induced analgesia in mice. Eur J. Pharmacol. 168: 61-70, 1989.
32. SUH, H. H. AND TSENG, L. F.: Differential effects of sulfated cholecystokinin octapeptide and proglumide injected intrathecally on antinociception induced by β-endorphin and morphine administered intracerebroventricularly in mice. Eur. J. Pharmacol. 179: 329-228, 1990a.
33. SUH, H. H. AND TSENG, L. F.: Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and ß-endorphin in mice. Naunyn-Schmiedeberg's Arch. Pharmacol. 342: 67-71, 1990b.
34. SUH, H. H., TSENG, L. F. AND LI, C. H.: β-Endorphin(1-27) antagonizes β-endorphin- but not morphine-, D-PEN2-D-PEN5-enkephalin- and U50,488H-induced analgesia in mice. Neuropharmacology 27: 957-963, 1988.
35. TAKEMORI, A. H. AND PORTOGHESE, P. S.: The mixed antinociceptive agonist-antagonist activity of β-endorphin(1-27) in mice. Life Sci. 53: 1049-1052, 1993.
36. TALLARIDA, R. J. AND MURRAY, R. B.: Manual of Pharmacologic Calculations with Computer Programs, Springer-Verlag, New York, 1987.
37. 125I]-β-endorphin binding sites. Life Sci. 56: PL97-PL102, 1995.
38. TSENG, L. F. AND COLLINS, K. A.: Different mechanisms mediating tail-flick inhibition induced by β-endorphin, DAMGO and morphine from ROb and GiA in anesthetized rats. J. Pharmacol. Exp. Ther. 257: 530-538, 1991.
39. TSENG, L. F. AND COLLINS, K. A.: Cholecystokinin administered intrathecally selectively antagonizes intracerebroventricular β-endorphin-induced tail flick inhibition in the mouse. J. Pharmacol. Exp. Ther. 260: 1086-1092, 1992.
40. TSENG, L. F. AND TANG, R.: Different mechanisms mediate β-endorphin- and morphine-induced inhibition of the tail-flick response in rats. J. Pharmacol. Exp. Ther. 252: 546-551, 1990.
41. UNAL, C. B., OWEN, M. D ANB MILLINGTON, W. R.: β-Endorphin-induced cardiorespiratory depression is inhibited by glycl-1-glutamine, a dipeptide derived from β-endorphin processing. J. Pharmacol. Exp. Ther. 271: 952-958, 1994.
42. URBAN, M. O. AND SMITH, D. J.: Role of neurotensin in the NRM in opioid induced antinociception from the PAG. J. Pharmacol. Exp. Ther. 265: 580-586, 1993.
43. URBAN, M. O. AND SMITH, D. J.: Localization of the antinociceptive and antianalgesic effects of neurotensin within the rostral ventromedial medulla. Neurosci. Lett. 174: 21-25, 1994.
44. VAUGHT, J L., ROTHMAN, R. B. AND WESTFALL, T. C.: Mu and delta receptors: Their role in analgesia and in the differential effects of opioid peptides on analgesia. Life Sci. 30: 1443-1455, 1982.
45. WUSTER, M., SCHULZ, R. AND HERZ, A.: Specificity of opioids towards the μ-, δ-, and ∈-opiate receptors. Neurosci. Lett. 15:193-198, 1979.